GRI

1.1200.00%
RR

Roelof Rongen

Independent Director

Mr. Roelof Rongen, MSE, M.B.A., serves as Independent Director of GRI Bio, Inc. from April 2023. He is Managing Partner of AsteRx Pharma Consulting and Founder/Chief Executive Officer of Innovative Molecules. He serves as CEO & Director of Adolore Biotherapeutics, Inc. since January 2023. He is a Co-Founder of Matinas Biopharma, Inc. and was its Chief Executive Officer and President since April 2012. Mr. Rongen served has been the Chief Executive Officer at Matinas BioPharma Holdings, Inc. since July 2013 until March 16, 2018. He served as President of Matinas BioPharma Holdings, Inc. from July 2013 to March 7, 2016. He is a serial entrepreneur, company builder and R&D/Commercial Development leader with extensive experience across many therapeutic areas and functions. He served as Vice President of Product Life Cycle Management and Intellectual Property at Reliant Pharmaceuticals, Inc. He joined Reliant in May 2000 as Director of Business Development. Mr. Rongen served as Executive Vice President North American Operations for EPAX/Trygg Pharma. Mr. Rongen served as the Head of the Omacor®/Lovaza® launch team, Executive Director of Marketing for Lescol® and Executive Director of Business Development while at Reliant. He served as Global Product Director for Humira® at BASF Pharmaceuticals. He was a consultant at The Wilkerson Group in New York and with Arthur D. Little in Amsterdam. Mr. Rongen joined Reliant from BASF Pharma, where he was responsible for global commercial development for Humira. He was a Management Consultant at The Wilkerson Group in New York City and Arthur D. Little in Amsterdam, specializing in the pharmaceutical industry. He is the Founder and serves as the Chairman of Essential Fatty Acid Therapeutics. He has been a Director of Matinas BioPharma, Inc since April 2012. He served as Director of Matinas BioPharma Holdings, Inc. since July 2013. He received Master of Science in Engineering (MSE) in Molecular Sciences (with Biotechnology/Bio-Process Technology focus) graduate degree from Wageningen University in the Netherlands. Mr. Rongen received his M.B.A. from Northwestern's Kellogg Graduate School of Management at Northwestern University.

Positions